Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Washington based Founder operating in the Health Care space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Founder & CEO of Viome
Naveen Jain is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation. He is the founder of several successful companies including Moon Express, BlueDot, Viome, Intelius, TalentWise and InfoSpace. Moon Express is the only company to have permission from the US government to leave earth orbit and land on the moon. It’s developing technologies to harvest planetary resources on the moon for the benefit of humanity. BlueDot is focused on bringing most promising technological innovations from the national labs, NASA and elite universities and supercharging them with great entrepreneurs to create successful enterprises that tackle humanity’s grand challenges. Viome is focused on discovering predictive biomarkers to eradicate all diseases. Our initial goal is to provide personalized diet & nutrition based on deep analysis of microbiome, metabolome and meta genomics. Naveen Jain a trustee of the board and vision circle member at the X PRIZE Foundation where he is focused on finding entrepreneurial solutions to address the global challenges in health, education, women empowerment, agriculture, and energy. Naveen Jain is on the board of Singularity University, an interdisciplinary university with the mission to educate and inspire leaders to address humanity’s grand challenges through innovative technologies. Naveen Jain has been awarded many honors for his entrepreneurial successes and leadership skills including “Ernst & Young Entrepreneur of the Year”, “Albert Einstein Technology Medal” for pioneers in technology, “Humanitarian Innovation Award” at the United Nations, “Distinguished Global Thinker Award” by IILM, “Most inspiring Entrepreneur” by Andaaz TV, “Most admired Serial Entrepreneur” by Silicon India, “Top 20 Entrepreneurs” and “Lifetime Achievement Award” for the leadership in the technology industry and support of other entrepreneurs by Red Herring.
Follow Naveen Jain:
About Bellevue LifeSpring, BlueDot, Moon Express, TalentWise, Viome, World Innovation Inc: Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.
Mitchell Rales
Co-Founder of Danaher
Mitchell Rales is a co-founder of Danaher and has served on Danaher’s Board of Directors since 1983, serving as Chairman of the Executive Committee of Danaher since 1984. He was also President of Danaher from 1984 to 1990. In addition, for more than the past five years he has been a principal in private and public business entities in the manufacturing area. Mitchell is a member of the board of directors of Colfax Corporation, and is a brother of Steven Rales. The strategic vision and leadership of Mitchell and his brother, Steven Rales, helped create the Danaher Business System and have guided Danaher down a path of consistent, profitable growth that continues today. In addition, as a result of his substantial ownership stake in Danaher, he is well-positioned to understand, articulate and advocate for the rights and interests of Danaher’s shareholders.
Follow Mitchell Rales:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Steven Rales
Co-Founder of Danaher
Steven Rales is a co-founder of Danaher and has served on Danaher’s Board of Directors since 1983, serving as Danaher’s Chairman of the Board since 1984. He was also CEO of Danaher from 1984 to 1990. In addition, for more than the past five years he has been a principal in private business entities in the area film production. Steven is a brother of Mitchell Rales. The strategic vision and leadership of Steven and his brother, Mitchell Rales, helped create the Danaher Business System and have guided Danaher down a path of consistent, profitable growth that continues today. In addition, as a result of his substantial ownership stake in Danaher, he is well-positioned to understand, articulate and advocate for the rights and interests of Danaher’s shareholders.
Follow Steven Rales:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Bijan Salehizadeh
Founder and Managing Director of NaviMed Capital
Bijan has over 15 years of operational and investment experience in healthcare IT and products. He currently serves as managing director and co-founder at NaviMed Capital, a private investment firm based in Washington, DC where he focuses on growth venture capital healthcare investments in healthcare IT / analytics and healthcare services. Prior to co-founding NaviMed, he was a General Partner at Highland Capital Partners, a multi-billion dollar investment firm where was responsible for leading many of the firm’s healthcare transactions over a decade. Prior to joining Highland in 2003, Bijan spent several years at Medtronic, a global medical products and solutions company. Before Medtronic, he was an early employee at and held a variety of senior management roles at HealthCentral, a venture capital-backed healthcare IT company that went public in 1999. He is currently on the board of directors and advisory committees of numerous healthcare data and products companies including Auris Surgical, Hyperion Therapeutics (IPO), kyruus, and Procured Health, and has sourced or been actively involved in investments in AVEO Oncology (IPO), Baronova, BÂRRX Medical (sold to Covidien), Conor Medsystems (IPO; sold to Johnson & Johnson), and Pharmaca Integrative Pharmacy. Bijan holds an A.B. in Molecular Biology from Princeton University, an M.D. and Master’s in Science in Healthcare Policy from Columbia University, and an M.B.A. from Harvard Business School. He is also a graduate of the Kauffman Fellows Program and has been published in several peer-reviewed journals.
Follow Bijan Salehizadeh:
About NaviMed Capital: NaviMed Capital is a Washington-DC based lower-middle market growth buyout firm focused on healthcare.
Mike McSherry
CEO & Founder of Xealth
CEO at Xealth.
Follow Mike McSherry:
About Xealth: Xealth is a platform for digital health, enabling clinicians to prescribe and monitor digital tools from within the EHR workflow.
Eric Fu
Co-Founder and CTO of Xealth
Eric Fu is Co-d=founder and Chief Technology Officer at Xealth. Before this, he was with Providence Health & Services as resident entrepreneur. He was director of engineering at Nuance Communications as well.
Follow Eric Fu:
About Xealth: Xealth is a platform for digital health, enabling clinicians to prescribe and monitor digital tools from within the EHR workflow.
Connie Wan
Founder and CEO of Seattle Gummy Company
Connie Wan Business, technology and IP executive with proven sucess in technology and product development and commercialization; intellectual property creation, portfolio strategies, management and commercialization; IP landscape and whitespace analysis; patentability search; patentability and freedom to operate analysis and opinions; IP due diligence; patent validity and infringement analyses; IP assets evaluation, acquisition, and licensing; technology transfer; IP strategy, patent portfolio development and trademark strategy for startups; inventors training, development, and management; patent preparation and prosecution in the fields of chemistry, pharmaceutics, therapeutic methods, biotechnology, medical devices, polymers, material sciences, and nanotechnology; design patent preparation and prosecution; client counseling and case management; trademark searches and availability opinions; trademark registrations, oppositions, and cancellations; and limited amount of copyright work.
Follow Connie Wan:
About Seattle Gummy Company: A specialty pharma company focusing on delivering drug ingredients (APIs) using innovative gummy (chewable gel) formulations.
Sahil Diwan
Co-Founder & CEO of SafKan Health
Follow Sahil Diwan:
About SafKan Health: Ear care for the 21st century.
Aadil Diwan
Co-Founder & CTO of SafKan Health
Follow Aadil Diwan:
About SafKan Health: Ear care for the 21st century.
Steve Arnold
Co-Founder and Partner Emeritus of Polaris Partners
Prior to starting Polaris, Steve served as a special advisor to Burr, Egan, Deleage & Co. following more than 10 years in executive positions in the software industry. He served as vice president of Broadband Media Applications at Microsoft Corporation and as president and CEO of Continuum Productions (now Corbis), a private company founded by Bill Gates to pioneer the creation of large digital libraries for online distribution. Before coming to Continuum, Steve served as vice president and general manager of LucasArts Games and Learning divisions, and vice president of the New Media Group at Lucasfilm Ltd. He continues to serve as vice chairman of the board of directors of the George Lucas Educational Foundation. Steve holds a BS with honors from Macalester College and an MA and PhD from the California Institute of Integral Studies (CIIS) in San Francisco.
Follow Steve Arnold:
About Polaris Partners: Polaris Partners invests in healthcare and technology companies across all stages from founding to profitable growth.
Jack Miller
Co-Founder of bttn.
Jack is currently the Co-Founder of bttn. Jack has spent time working in both enterprise technology and building international supply chains. During the pandemic, Jack coordinated the delivery of 60M units to thousands of front line workers. Through these experiences, he decided to co-found Buttonwood Inc DBA bttn. Jack is skilled at securing key partnerships and leading long term technological and logistical vision. Prior to bttn. Jack worked for NetApp as a Solutions Engineer helping implement data focused technologies at companies like McKesson, LucasFilm, Pixar, and Disney+
Follow Jack Miller:
About bttn.: bttn. offers subscription-based ordering on direct-from-manufacturer medical supplies.
James C. Katzaroff
CEO, Chairman and Founder of Vivos Inc
A serial entrepreneur who started his first company importing minerals and pewter from Brazil while in high school in southern California, Mr. Katzaroff is constantly searching for outstanding opportunities. Hired straight out of college Mr. Katzaroff was a financial consultant for Wall Street firms Bateman Eichler, Smith Barney and EFHutton. Since 1990, he has been responsible for corporate engineering, senior-level corporate strategy, fostering investment bank relationships, and has served as a senior financial advisor for numerous start-ups and development stage companies. A strong desire to make an unshakable impact in the fight against cancer led Mr. Katzaroff to found AMI in 2006.
Follow James C. Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Ethan D. Leder
Co-Founder, Partner & Executive Chairman of Precision Medicine Group
Ethan Leder is the Co-Founder and Executive Chairman of Precision Medicine Group. Over the past 25 years, he has been an entrepreneur focused on building and managing innovative, market-leading companies that address critical gaps in the healthcare industry. Prior to Precision Medicine Group, Leder was the Founder and CEO of United BioSource Corporation (UBC), which became the leader in real-world research addressing safety, value, and comparative effectiveness for the life science industry. UBC was acquired by Medco Health Solutions in late 2010 and is now part of Express Scripts. Before UBC, Ethan was the Co-Founder and CEO of U.S. Bioservices, Inc., which addressed a growing need for personalized, direct-to-patient distribution of high-cost biotechnology for serious medical conditions. U.S. Bioservices was acquired by AmerisourceBergen in 2002. Prior to U.S. Bioservices, he was the Founder and President of HealthCare Financial Partners, the leading specialty lender to the healthcare industry. It was acquired by GE Capital in late 1999. Ethan received his undergraduate degree from Johns Hopkins University and his Juris Doctor from Georgetown University Law Center. He also serves on the Board of Trustees of Johns Hopkins University and is active in many charitable and community development projects in the Washington DC, metropolitan area.
Follow Ethan D. Leder:
About Precision for Medicine, Precision Medicine Group: Precision Medicine Group accelerates values and improve outcomes for innovative pharmaceutical and life science companies.
Ryan Drant
Founder & Managing Partner of Questa Capital Management
Ryan joined NEA in 1996, and became a General Partner in 2004. He specializes in healthcare investments in the medical device, healthcare information technology and specialty pharma sectors. Present board memberships include BENU, Carticept Medical, Concentric Medical, CVIngenuity, DSI Renal, ExploraMed III, Intrinsic Therapeutics, Neotract, PatientKeeper, Simplex Healthcare, Solace Therapeutics, Spine Wave, TriVascular, Ulthera and Vibrynt. Ryan also serves on the board of the Medical Device Manufacturers Association. Past board memberships include ESP Pharma (acquired by Protein Design Labs, Inc.), Esprit Pharma (acquired by Allergan), FoxHollow Technologies (acquired by EV3, now Covidien), Provation Medical (acquired by Wolters Kluwer), and Proxima Therapeutics (acquired by Cytyc Corporation, now Hologic), and Ryan co-led NEA’s investment in Xcel Pharmaceuticals (acquired by Valeant Pharmaceuticals, Inc.). Prior to joining NEA, Ryan was with the Health Care Investment Banking Group of Alex. Brown & Sons in San Francisco. Previously, he worked in the San Francisco office of Arthur Andersen & Co. Ryan received a BA from Stanford University.
Follow Ryan Drant:
About Questa Capital Management: Questa Capital Management is a healthcare venture growth equity firm investing in breakout growth companies.
Michel Sadelain
Scientific Co-Founder of Juno Therapeutics
Dr. Michel Sadelain is Head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr. Sadelain’s research focuses on novel approaches to enhance T cell costimulation and function. His clinical program focuses on B cell malignancies as well as solid tumors. Dr. Sadelain is the incumbent of the Stephen and Barbara Friedman Chair and the founding director of the Center for Cell Engineering at MSKCC. He previously served on the board of directors of the American Society of Gene Therapy (2004-2007) and continues to serve on the editorial boards of Molecular Therapy, Human Gene Therapy and Gene Therapy.
Follow Michel Sadelain:
About Juno Therapeutics: Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Isabelle Rivière
Scientific & Co-Founder of Juno Therapeutics
Isabelle Rivière received her Ph. D. in Cellular and Molecular Biology from the University of Paris in 1993. She initiated her graduate studies in the Interferon Research Group at the Institut Curie, Paris and completed her thesis work in the laboratory of Richard Mulligan,Ph.D at the Whitehead Institute for Biomedical Research, Cambridge, MA. During this time, she developed the MFG/SFG-based gamma-retroviral vectors for in vivo long-term expression of transgenes in hematopoietic cells, which are currently used in multiple clinical trials for the treatment of hereditary blood disorders and cancer. She subsequently worked as a postdoctoral fellow in the laboratory of Dan Littman, MD, Ph.D at New York University, New York, NY. Her studies focused on the regulation of cytokines produce by T helper lymphocytes in vivo, based on a mouse model she developed to track IL-4 secreting T cells using homologous recombination in embryonic stem cells. Dr. Rivière joined the faculty of the Memorial Sloan-Kettering Cancer Center (MSKCC) in 1999. She is currently the Director of the Cell Therapy and Cell Engineering Facility where she investigates novel strategies for cell therapies and immunotherapies to increase or retarget the immune response against tumors and treat hematological disorders. Her laboratory has developed multiple processes for clinical-grade gamma-retroviral and lentiviral vector production as well as hematopoietic and T cell manufacturing. Dr. Rivière serves on the editorial board of Molecular Therapy: Methods and Clinical Development and on multiple committees of the Association of Academic Biologics Manufacturers (AABM), the International Society for Cellular Therapy (ISCT) and the American Society of Gene & Cell Therapy (ASGCT).
Follow Isabelle Rivière:
About Juno Therapeutics: Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Stan Riddell
Scientific Co-Founder of Juno Therapeutics
Stan Riddell is a member of the Clinical Research Division at Fred Hutchinson Cancer Research Center and Professor of Oncology at the University of Washington School of Medicine. Dr. Riddell is a leader in developing therapies that harness the immune system to fight cancer and infectious diseases. His research led to patented technologies that rapidly expand the number of disease fighting T cells used in adoptive immunotherapy. He also isolated a rare subset of disease-fighting T cells that survive in patients for an extraordinary amount of time. In 2010, Dr. Riddell received the International Society for Biological Therapy of Cancer’s first Team Science Award for major contributions to research and the clinical translation of cancer immunotherapy. Dr. Riddell received his M.D. from the University of Manitoba in Winnipeg. He joined FHCRC Faculty in 1991 after training in medical oncology and immunology. Dr. Riddell was recently elected to the Association of American Physicians, an organization honoring those who have achieved excellence in biomedical science.
Follow Stan Riddell:
About Juno Therapeutics, University of Washington: Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Jannine Versi
COO and Co-Founder of Elektra Health
Jannine Versi joined the International Trade Administration as Chief of Staff to the Under Secretary of Commerce for International Trade in August 2014. Previously, she worked as a Product Marketing Manager at Google, where she focused on strategy and operations for the Senior Vice President and Global Head of Marketing, and helped to grow Google’s business in the Middle East and North Africa. Jannine spent time in India researching economic development as Fulbright Scholar and also interned in the White House at the National Economic Council. She holds a BA in International Relations from the University of Pennsylvania and an MBA from Harvard Business School.
Follow Jannine Versi:
About Elektra Health, International Trade Administration: Elektra Health is a new healthcare platform on a mission to tackle the menopause taboo for women.
Rob Lawson-Shanks
CTO & Co-Founder of LifeFuels
Follow Rob Lawson-Shanks:
About LifeFuels: LifeFuels is changing the way consumers approach hydration and nutrition by empowering them to create personalized beverages on the go.
Thomas N. Chase
Founder, Chief Scientific Officer of Chase Pharmaceuticals
Dr. Thomas N. Chase, SD, MD, a co-founder of Chase Therapeutics Corporation, currently serves as its President and Chief Executive Officer . He has over 40 years experience in the discovery and development of novel pharmaceuticals for central nervous system disease, first at the National Institutes of Health (NIH) and later as a founder and manager of specialty pharmaceutical companies. Dr. Chase has extensive experience in drug discovery and development for central nervous system disorders and has designed and overseen clinical studies for over 100 INDs related to the treatment of indications in neurology and psychiatry. While at the National Institutes of Neurological Disorders and Stroke (NINDS) of the NIH. Dr. Chase served there as Scientific Director, Intramural Research Director, Clinical Director, and founding chief of the Experimental Therapeutics Branch. His team contributed to the discovery and development of several of the major drugs now marketed for Parkinson’s disease. He left the federal government in 2005 to co-found and lead Hamilton Pharmaceuticals, Inc. Upon its acquisition by another pharmaceutical company, he become the Co-founder, President and Chief Executive Officer of Chase Pharmaceuticals, acquired by Allergan in 2016. Subsequently, Dr. Chase co-founded Riverside Pharmaceuticals and currently serves as President and Chief Executive Officer of that company as well as of Chase Therapeutics. He coauthored more than 500 peer reviewed medical-scientific publications and over 80 patents. Dr. Chase was the founding President of the American Society of Experimental Neuro Therapeutics (ASENT) and is a member of numerous other professional associations and journal editorial boards. He received both the Superior and the Distinguished Service Medals from the U.S. Public Health Service as well as awards from Yale University, the Johann Wolfgang Goethe University of Frankfurt, the American Parkinson’s Disease Association, National Parkinson Foundation, American Academy of Neurology, Movement Disorders Society, and the governments of Bolivia and Pakistan. Dr. Chase graduated from the Massachusetts Institute of Technology and Yale University School of Medicine. He completed neurology residency training at Harvard Medical School and the Massachusetts General Hospital and conducted postdoctoral studies in basic and clinical neuropharmacology at the National Institute of Mental Health (NIMH) before transferring to the NINDS.
Follow Thomas N. Chase:
About Chase Pharmaceuticals, Chase Therapeutics: Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.
Kyle Hendrick
Founder & General Partner of AAF Management Ltd.
Kyle has lead direct investments in over 90+ early stage companies with over 500 tier 1 and tier 2 venture capital firms and corporate venture arms participating in the deals. He has LP exposure to over 17 venture capital funds globally and is an investment committee member at KBBO Ventures a $100M venture arm of KBBO Group in Abu Dhabi.
Follow Kyle Hendrick:
About AAF Management Ltd., GoldCleats Global: AAF Management Ltd. is an early-stage VC firm focused on Seed and Series A technology companies.
Michael Richman
Co-Founder, President & CEO of NextCure
Michael Richman has over 24 years of experience working in research, intellectual property and business development capacities in companies such as Chiron Corporation (now Novartis) and MedImmune, Inc. (now Astra Zeneca), where he was Senior Vice President Corporate Development prior to taking on his most recent position at MacroGenics. While at MedImmune, Michael was responsible for all Business Development, Licensing, Intellectual Property, Legal Affairs, Project Management and Strategic Planning functions, and drove over $1.6 billion in transactions. His transactional and M&A experience, management skills and familiarity with the scientific and intellectual aspects of biotechnology product development are invaluable in building young companies. Most recently, Michael was Executive Vice President and Chief Operating Officer at MacroGenics – a fully integrated R&D company focused on monoclonal antibodies for cancer, autoimmune diseases, and infectious diseases. Michael obtained his B.S. in Genetics/Molecular Biology at the University of California at Davis and his M.S.B.A. in International Business at San Francisco State University.
Follow Michael Richman:
About NextCure: NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Justin Klein
Co-Founder & Managing Partner of Vensana Capital
Justin joined NEA in 2006 and is a Partner on the healthcare team. He focuses on medical device, healthcare technology, and biopharmaceutical company investments. He serves as a director of Advanced Cardiac Therapeutics, Cartiva, FIRE1, Intact Vascular, PhaseBio Pharmaceuticals, Relievant Medsystems, Senseonics, VertiFlex, and VytronUS. Justin’s past board memberships and investments include CV Ingenuity (acquired by Covidien), Nevro (NYSE: NVRO), Topera (acquired by Abbott), TriVascular (NASDAQ: TRIV), and Ulthera (acquired by Merz). He is also a member of the advisory boards for the National Venture Capital Association’s Medical Industry Group and its Medical Innovation and Competitiveness Coalition (MedIC), as well as a member of AdvaMed’s Business Development Committee. Prior to NEA, Justin worked for the Duke University Health System—reporting directly to the hospital CEO on health system strategy, finance and clinical service unit operations—as Duke built one of the nation’s first and largest healthcare integrated delivery systems. Justin concurrently earned his MD from the Duke University School of Medicine and his JD from Harvard Law School. He has also served as a member of the Board of Trustees of Duke University, where he earned his AB in Economics and his BS in Biological Anthropology and Anatomy.
Follow Justin Klein:
About Vensana Capital: Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
Meghan Gaffney Buck
Founder & CEO of VEDA Data Solutions
Meghan is a founding partner in VEDA Data Solutions and leads business development, partnerships, and fundraising. Meghan leverages over 15 years working with senior elected officials to identify opportunities for new technology that enables businesses to thrive in our current regulatory environment. She is also a founding partner of LOOP LLC, a market research and analytics company serving the music and entertainment industry.
Follow Meghan Gaffney Buck:
About VEDA Data Solutions: VEDA is an AI and machine learning platform to save healthcare and administrative costs.
Jenny Abramson
Founder & Managing Partner of Rethink Impact
Jenny Abramson joined Rethink Impact as Founder & Managing Partner in 2015.
Follow Jenny Abramson:
About Rethink Capital Partners, Rethink Impact: Rethink Impact is a venture capital firm investing in female leaders using technology to solve the world’s biggest problems.
Chris Gibbons
Founder & CEO of The Greystone Group, Inc.
Chris Gibbons is a physician, health innovator and entrepreneur with a passion for digital health health innovation and diversity. He is currently The Chief Health Innovation Adviser for the Federal Communications Commission’s Connect2Health Task Force and the Founder & CEO of The Greystone Group, Inc., a health technology research, innovation and incubation company. Previously Dr. Gibbons was an Associate Director of the Johns Hopkins Urban Health Institute, and an Assistant Professor of Medicine, Public Health and Health Informatics at Johns Hopkins University where he currently remains as an adjunct assistant professor. He is a recognized health innovator, published author and international speaker who has authored over 75 scientific papers, books, book chapters and technical reports. Dr. Gibbons obtained his medical degree from the University of Alabama and then completed residency training in Preventive Medicine, a basic science research fellowship and a Master of Public Health degree all from Johns Hopkins.
Follow Chris Gibbons:
About Duke University School of Medicine, Johns Hopkins University School of Medicine, The Greystone Group, Inc.: The Greystone Group, Inc. is a health technology innovation company focused on multicultural innovators and solutions.
Seth Brickman
Co-Founder, Head of Product and Operations of Nicolette
Seth joined Nicolette out of his belief that we are all here for a purpose bigger than ourselves and helping patients and providers partner in healthcare helps accomplish that. Seth is a veteran of the US Navy and has been a senior executive at several companies including Microsoft and Holland America cruise line.
Follow Seth Brickman:
About Nicolette, Qcash Financial: Nicolette operates as a patient empowerment company.
Kevin Nazemi
Co-Founder & CEO of Renew Health
CEO & Co-Founder at Done.
Follow Kevin Nazemi:
About Renew Health: Renew Health’s mission is to fundamentally transform how medications are managed in the health care system.
Chad Robins
Co-Founder, President & CEO of Adaptive Biotechnologies
Chad Robins is Adaptive’s President, Chief Executive Officer and Co-founder. He has held executive-level positions in real estate, investing and medical technology, including: Pulte Homes, Connaught Real Estate Finance, and HealthAxis.com. Chad Robins started his career in banking for companies such as Wasserstein Perella and Bank of America. In 2012, Chad Robins was a “40 Under 40” Seattle Leaders honoree. In 2015, he and his brother, Harlan Robins, were honored as one of Goldman Sachs 100 Most Intriguing Entrepreneurs of the Year. Chad Robins was also a finalist for the Ernst & Young 2016 Entrepreneur Of The Year® Award in the Pacific Northwest. While in college and looking for a way to combine his adventuresome spirit with a vast learning opportunity, he spent 100 days in the wilderness with the National Outdoor Leadership School (NOLs) where he gained his open and interactive leadership style along with his strong teamwork mentality. A Cornell University honors graduate with a major in entrepreneurship and business, Chad Robins obtained his MBA from The Wharton School at the University of Pennsylvania with a major in finance and concentrations in marketing and operations. In addition to the Adaptive Biotechnologies board, Chad Robins holds board positions for the American Heart Association (Puget Sound) and Pavia Systems. He is also the co-founder and Director of Aortica Corporation, a company that is simplifying endovascular repair (EVAR) for abdominal aortic aneurysms (AAA).
Follow Chad Robins:
About Adaptive Biotechnologies: Adaptive Biotechnologies translates a scale and precision of the adaptive immune system into products to diagnose and treat disease.
Vincent Lopez
Founder & CEO of LCA Vantage
Vincent Lopez is a Mexican-American entrepreneur, and the founder & CEO of LCA Corp., which manages investments in various industries, including healthcare, technology, and media. Mr. Lopez is the founder & CEO of LCA Vantage Healthcare, a transformative cost-saving market-disrupting solution to America’s crippling healthcare system. Throughout his career, Mr. Lopez has held several esteemed positions including a 2015 nomination by Governor Tom Wolf (D-PA) to the Pennsylvania State System of Higher Education, Board of Governors. He completed a Fellowship in STEM (Science, Technology, Engineering, & Math) education targeted in minority neighborhoods, with President Obama’s Organizing for Action. He’s served as a law enforcement officer. He’s worked for the U.S. Department of Homeland Security. Subsequently, he went on to work for notable U.S. Government Contractors. He is the founder & CEO of the Lopez Foundation, Inc., a 501 (c)(3) non-profit, which focuses on establishing lifelong success in our schools, communities, and our working world. The Foundation believes in its core principles to “Teach, Inspire, Empower, & Lead” the next generation. He studied at the Indiana University of Pennsylvania, where he majored in English, political science, and government (Pre-law). He’s an avid fan of Formula 1 racing, horse racing, and fishing.
Follow Vincent Lopez:
About LCA CORP, LCA Vantage, The Lopez Foundation,Inc.: Electronic Health Records, Remote Physiological Monitoring, Biometrics, FHIR Complaint, Health Subscriptions
Darryl Rawlings
Founder & CEO of Trupanion
Darryl Rawlings is an animal lover and serial entrepreneur. As Trupanion’s CEO and founder, he brought transparency and value to the pet insurance business. His appreciation of the special relationship between pets, pet owners and veterinarians led him to invent a new kind of pet insurance. Trupanion insurance is designed to ensure that pet owners and veterinarians can make the best decisions about a pet’s health. It does not punish pet owners for making claims. It is the only pet insurance that has no limits. Trupanion is an industry leader in terms of its product, but also in terms of its organization. In order to provide high quality customer service, Darryl developed the concept of Territory Partners, who work closely with veterinarians and are vested in the long-term success of Trupanion. Everything about the company is designed to create long-term alignment between all stakeholders. Darryl was born in Vancouver, Canada, and studied business at BCIT. Before his launch as an entrepreneur, he worked as Director of Sales and Marketing at Telos Engineering, where he was responsible for cellular network sales in North and South America and Africa. Before that, he sold encryption technology to the cellular and military markets at Cycomm International. In 1994 he founded his first business, the Canadian Cigar Company. As an international importer of over 1,000 varieties of quality cigars, the Canadian Cigar Company served international cigar club proprietors, four-star hotels and bars, exclusive golf resorts, and retail stores. Darryl successfully grew the company and sold it in 1999. He used the proceeds from the sale to found Trupanion (as Vetinsurance, in Canada) in 1999. Between 1999 and 2005 Darryl refined his pet insurance product and business model in Canada. In 2004 the company became the first profitable North American pet health insurance provider, and a year later had grown by 4% per month for the previous twenty-four months, with the highest rates of retention and consumer satisfaction in the industry. In 2005, Darryl decided to expand into the United States and to become the first North American pet insurance provider to become licensed to do its own underwriting. In 2007, the company raised $22 million from Maveron (a leading VC fund specializing in consumer branded products), RenaissanceRe ($4 billion reinsurance company) and a large private equity group. The company was rebranded as Trupanion. In 2008, a Series B round followed. Darryl balances his time between building the world’s best pet insurance company and his wife Caroline and their two young sons, Sam and Bennett. Occasionally he gets in a day of boating.
Follow Darryl Rawlings:
About Trupanion: Trupanion is an insurance company which provides pet care insurance.
Co-Founder of Hybrent
Navneet Gosal Former CTO, and founding team member of the original Carefusion, Navneet now enjoys creating and operating new businesses with technology focus – like working with entrepreneurs as they try to build something that can scale and be interesting. Solving problems in small gaps in existing systems that can yield big efficiencies.
Follow Navneet Gosal:
About Hybrent, India Venture Partners: Hybrent is committed to improving the current state of healthcare by providing groundbreaking technology
Justin Kowalchuk
CEO and Founder of MedBridge
CEO and Founder at MedBridge.
Follow Justin Kowalchuk:
About MedBridge: MedBridge is a provider of patient engagement and clinical education solutions for healthcare professionals.
Hossein Noshirvani
Founder & EVP of Motionsoft
Hossein is the President of CharityEngine which makes software for nonprofits so they can manage tasks like events management, online fundraising and email marketing. Hossein is also the Co-Founder of Motionsoft and former Executive Vice President for Motionsoft and is the head of Motionsoft’s marketing team. He has been involved in the health and wellness industry for over nine years and has in-depth knowledge and keen insight into the industry.
Follow Hossein Noshirvani:
About Dolly Drive, Motionsoft: Motionsoft provides fitness, gym, and recreation club management and marketing software solutions.
Allan Njoroge
Founder and CEO of Actriv Healthcare
Founder & CEO of Actriv Healthcare Inc.
Follow Allan Njoroge:
About Actriv Healthcare, Autorgy: Connecting Nurses(CNA,LPN,RN) with Healthcare Facilities looking for contingent staff.
John Payne
CEO & Founder of Pet Health Innovations
Payne was appointed director on July 19, 2013. He brings more than 30 years’ experience in the global animal health industry to the HEPI board. Payne previously served as President and CEO of Banfield Pet Hospitals, leadership team member for Mars Global PetCare, and President and General Manager of Bayer Healthcare’s North American Animal Health Division. Payne is also CEO and Founder of Pet Health Innovations, LLC. He has been honored for his commitment to bringing human quality medicine and healthcare to pets, and has gained worldwide recognition.
Follow John Payne:
About Pet Health Innovations, Zivo Bioscience: Pet Health Innovations is a Health Care company.
Michele Kang
CEO & Founder of Cognosante
A visionary in the field of health information technology, Michele founded Cognosante in 2008 to disrupt and challenge the status quo in the U.S. healthcare system. Leveraging a unique set of business, data, and technical expertise in a fundamentally different way, Cognosante provides innovative solutions central to carrying out national healthcare transformation. Under Michele’s leadership, Cognosante has emerged as one of the most trusted partners of key Federal and state health agencies, while growing rapidly over the past five years. In the spring of 2017, Michele was named winner of the Women in Technology (WIT) Corporate Mid-Market Sector Award at its 18th Annual Leadership Awards in Washington, DC. In 2015, Michele was honored as EY Entrepreneur Of The Year® for the Washington, DC region, and then went on to win the U.S. Award for the Services category. In November 2015, Michele was named Executive of the Year among contracting organizations with revenues of $75 million to $300 million during the 13th Annual Greater Washington Government Contractor Awards™. She also received the 2012 Mosaic Woman Trailblazer Award from Diversity Woman magazine in recognition of her outstanding accomplishments and leadership in business. Michele is actively engaged in promoting Science, Technology, Engineering, and Math (STEM) studies and careers for girls and women. In 2012, she was elected along with U.S. senators, high-ranking government officials, and top executives of Fortune 500 companies as an inaugural member of 100 Women Leaders in STEM. In 2016, STEMconnector® named her one of the “Top 100 CEO Leaders in STEM” in recognition of her deep personal commitment to the cause. To realize one of her lifelong passions, Michele launched the Cognosante Foundation in 2012. The Foundation is focused on helping underprivileged and underresourced individuals build meaningful professional careers and achieve financial independence. It has underwritten an annual fellowship program with the Young Invincibles for first-generation college students to develop critical skills and gain exposure to business and political environments that may otherwise be out of reach. Michele also has been a leader in Veterans causes, organizing the establishment, funding, and serving as chair of the National Women Veterans Committee for the Million Women Mentors (MWM) organization. In October 2016, Michele received the Veterans Service Award from MWM in recognition of her dedication to improving the lives and prospects for success of the nation’s 1.4 million female Veterans. Consistent with Cognosante’s overall vision, Michele established Cognosante Ventures to identify, invest in, and mentor emerging innovative health technology and data analytics companies. Cognosante Ventures focuses on building a portfolio of groundbreaking solutions and capabilities that can help fundamentally change the way healthcare is provided. To date, it has invested in four early-stage companies, and Michele serves on the board of three of these companies. Prior to founding Cognosante, Michele served as vice president and general manager of Northrop Grumman’s Health Solutions division, and as a management consultant helping global information, technology, and telecom companies formulate and successfully execute profitable growth strategies. Michele is an American Enterprise Institute National Council Co-Chair, a Kennedy Center Corporate Fund Vice Chair, and a member of the Kennedy Center International Committee on the Arts. She received a bachelor’s degree in economics from the University of Chicago and a master’s degree in public and private management from the Yale School of Management.
Follow Michele Kang:
About Cognosante: Cognosante is a provider of healthcare consulting, technology solutions, and business process outsourcing services.
Jim Harding
Founder & CTO of MultiScale Health Networks
Jim Harding is the Founder and Chief Technology Officer for MultiScale. As CTO, Mr. Harding is working to modernize how caregivers use patient data by enhancing EMR data to create on-demand, operational intelligence that drives collaboration and decision making. Mr. Harding previously held the role of Chief Executive Officer of MultiScale. Prior to founding MultiScale, Mr. Harding was Vice President of Technology at Amazon.com, where he led the business unit that developed the technology platform and marketing channel for all 3rd-party resellers to manage inventory and sell products through the Amazon website. His earlier career included founding ServerWare, which developed InfoModeler and later became part of Visio and Microsoft, as well as running Cartia, an award-winning pioneer in early, big data machine learning techniques, through a Battelle Labs tech transfer program.
Follow Jim Harding:
About MultiScale Health Networks: MultiScale Health Networks is a developer of real-time problem-solving solutions for healthcare.
Stefan Weitz
Founder & CEO of Jetson Health
Stefan Weitz is a Director of Search at Microsoft and is charged with working with people and organizations across the industry to promote and improve Search technologies. While focused on Microsoft’s product line, he works across the industry to understand searcher behavior and in his role as an evangelist for Search, gathers and synthesizes feedback to drive product improvements. Prior to Search, Stefan led the strategy to develop the next generation MSN portal platform and developed Microsoft’s muni WiFi strategy, leading the charge to blanket WiFi across metropolitan cities. A 12-year Microsoft veteran, he has worked in various groups including Windows Server, Security, and IT. Stefan is a huge gadget junkie and can often be found in electronics shops across the world looking for the elusive perfect piece of tech.
Follow Stefan Weitz:
About Jetson Health: The first and only Probiotic seasonally tailored to meet your body’s needs.
David Ross
CTO & Co-Founder of Twistle
Follow David Ross:
About Twistle: Twistle is a health care platform that helps healthcare providers connect with patients, keeping them on track for faster recovery.
Matthew Dowling
Founder and Chief Scientific Officer of Gel-E
Matthew Dowling, Ph.D. is Founder and Chief Scientific Officer of gel-e. Matt completed his graduate work at the Fischell Department of Bioengineering at the University of Maryland in May 2010 and has since pursued gel-e on a full-time basis. In 2005, after graduating in chemical engineering from the University of Notre Dame, he was awarded the Fischell Fellowship in Biomedical Engineering for his innovative ideas in drug delivery systems. Matt then co-created the gel-e platform, raising $165,000 in initial grants to develop the technology, which led to being named the Dean’s Doctoral Research Award from the UMD Clark School of Engineering for his work on chitosan-based self-assembled soft materials for use in wound treatment. He has since successfully licensed gel-e from UMD and has raised another $2.0M in non-dilutive funding which has been astutely used to achieve a first FDA clearance for gel-e, a large and growing patent estate and numerous peer-reviewed publications in high-impact journals.
Follow Matthew Dowling:
About Gel-E, Medcura: developed an advanced wound care platform designed to be used across a broad spectrum of clinical.
Parag Mallick
Founder, Chief Scientist of Nautilus Biotechnology
Parag Mallick is a Founder at Nautilus Biotechnology and Associate Professor at Stanford University.
Follow Parag Mallick:
About Nautilus Biotechnology: Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.
Scott Anderson
Co-Founder & CEO/CFO of Halfort Medical Solutions
Scott Anderson is the Chief Executive Officer and Chairman of Northeast Wireless Networks, LLC. Prior to joining Northeast Wireless Networks, LLC and since 1997-98, Scott Anderson has been a principal in Cedar Grove Partners, LLC, an investment partnership, and in Cedar Grove Investments, LLC, a private seed capital fund. In his role at Cedar Grove, Scott Anderson has had substantial investment and Board experience with early/later stage companies in a variety of industries, including wireless and teleco, petroleum engineering, retail coffee and defense contracting. From 1986 until 1997, Scott Anderson was employed by McCaw Cellular Communications and AT&T Wireless Services, Inc., where he served in various legal and M&A-related positions, last serving as Senior Vice President of the Acquisitions and Development group. In that role, he was oversaw all McCaw’s M&A, focusing on rural and smaller metropolitan markets. Before his employment at McCaw, Scott Anderson was engaged in private law practice in Seattle.Mr. Anderson is currently Chairman of the Board at Root Wireless and a director of Kratos Defense and Security, Inc., (NASDAQ: KTOS), mInfo Inc., Globys, Inc., Digital Scirocco, Inc. and Anvil Corporation.
Follow Scott Anderson:
About Cedar Grove Investments, Halfort Medical Solutions, Northeast Wireless Networks: Halfort Medical Solutions, healthcare staffing company, focuses on meeting urgent and short-term staffing needs of its clients.
Trenor Williams
Founder & Chief Executive Officer of Socially Determined
Williams is a family physician, entrepreneur, former CMIO and consulting executive and he most recently was the founder of Clinovations and former Managing Partner at the Advisory Board. In 2017, Dr. Williams founded a new company Socially Determined in order to create a service-enabled technology platform that integrates the social determinants of health with clinical data through the use of comprehensive care pathways and advanced analytics. With more than 20 years of healthcare experience, Dr. Williams’ unique perspective is formed at the intersection of healthcare and technology. He has an extensive understanding and knowledge in the implementation of healthcare technology, clinical process redesign, consumer market strategy development, and clinical adoption strategy development for leading hospital systems here in the United States and around the world. He has authored and edited several articles and books including: EHR for Dummies and Improving Medication Use and Outcomes with Clinical Decision Support: A Step-by-Step Guide, which received the 2009 HIMSS Book of the Year Award. Prior to starting Socially Determined and Clinovations, Dr. Williams led and supported engagements for Advanced Clinical Information Systems Implementations in both Inpatient and Ambulatory organizations. His expertise has helped organizations implement and optimize Computerized Physician Order Entries and develop strategies for achieving clinical, operational, and financial return on investment. Dr. Williams spent time in England working with the National Health Service to develop the national benefits that will measure every hospital in the country. He also helped healthcare communities redesign clinical care pathways for specific disease states in order to deliver improved and more efficient care. Dr. Williams’s subject matter expertise has helped clients develop physician adoption and clinical transformation methodologies and organize and motivate their clinical staffs during implementations. During these projects he worked side by side with clients to design and implement new governance structures, clinical content management strategies, clinician training plans and clinical workflow redesign efforts. Before beginning his consulting career, Dr. Williams was the medical director of Family Practice at Mammoth Hospital in California. He also served as a Lieutenant Commander in the United States Naval Reserve.
Follow Trenor Williams:
About Socially Determined: The social risk analytics company for organizations committed to addressing the Social Determinants of Health (SDOH)
Mary Bush
Founder & President of Bush International, LLC
The Honorable Mary Bush has served as President of Bush International, LLC, an advisor to U.S. corporations and foreign governments on international capital markets, strategic business and economic matters, since 1991. She has held several Presidential appointments including the U.S. Government’s representative on the IMF Board and Director of Sallie Mae. She also was head of the Federal Home Loan Bank System during the aftermath of the Savings and Loan crisis and was advisor to the Deputy Secretary of the U.S. Treasury Department. Earlier in her career, she managed global banking and corporate finance relationships at New York money center banks including Citibank, Banker’s Trust, and Chase. In 2006, President Bush appointed her Chairman of the Congressionally chartered HELP Commission on reforming foreign aid. In 2007, she was appointed by the Secretary of the Treasury to the U.S. Treasury Advisory Committee on the Auditing Profession. She is a member of the board of directors of Discover Financial Services, ManTech International Corporation, and T. Rowe Price Group, Inc. Bush also was a director of Briggs & Stratton, Inc. from 2004 to April 2009, of United Airlines from 2006 to 2010 and of the Pioneer Family of Mutual Funds from 1997 to 2012. She also serves on the Kennedy Center’s Community Advisory Board and on the U.S. Advisory Board of the Global Leadership Foundation. Bush has been a director of the Company since May 2008. Bush brings to the Board extensive financial and governmental affairs experience, her knowledge of corporate governance and financial oversight gained from her membership on the boards of other public companies, knowledge of public policy matters and her significant experience providing strategic advisory services in the political and international arenas.
Follow Mary Bush:
About Bush International, LLC: Bush International, LLC
Kiran Kalakuntla
Founder & CEO of ekincare
Seasoned product marketing professional with a track record of designing, developing and bringing complex technologies to market. Past launches include: World’s first 3D smartphone, first build to order smartphone, RFID etc.
Follow Kiran Kalakuntla:
About ekincare: ekincare is a corporate health benefits platform that provides healthcare intervention recommendations.
Ted T. Tanase
CEO & Founder of Ensocare
Follow Ted T. Tanase:
About Ensocare: Ensocare provides customer services and care coordination facilities to healthcare organizations to maximize their patient care facilities.
Sunny Singh
Founder of RoundGlass Partners
Follow Sunny Singh:
About RoundGlass Partners: RoundGlass Partners is a principle investment firm focused on investments in the healthcare industry.
Farhad Chowdhury
Founder & CEO of Vianova Health
Farhad is a CEO and Co-Founder of Vianova Health, which is a company reinventing home care. We personalize the technology and daily engagement to remotely care for your patients. Our Remote Health platform. Better health is defined by what a patient does at home between visits. Doc@Home makes the difference.
Follow Farhad Chowdhury:
About Vianova Health: Vianova Health is reinventing home care. We personalize the technology and daily engagement to remotely care for patients
Jill Angelo
Co-Founder & CEO of Gennev
Jill Angelo is the Founder & CEO of genneve, whose mission is to empower all women in menopause to take control of their symptoms. She is tech-exec-turned-women’s healthcare advocate bringing over 20 years of business and technology experience to women’s health innovation. Her last 15 years was spent at Microsoft in key executive roles such as Chief of Staff to the CMO, Senior Director of Global Media running a global team and multi-million dollar budget, and the Emerging Markets Products Leader, where she launched new products for the developing world. Jill also serves on the Board of Trustees for the Seattle Girls School.
Follow Jill Angelo:
About Gennev: Gennev is an online clinic for women in menopause.
Gundars Rezevskis
Business Strategy, Founder of myEmerg
Gundars loves to build brands that help simplify life, provide added value to people, and solve global issues. He envisions concepts that others have not uncovered and masterfully simplifies things by creating better products. He leads the company’s vision, design, and culture. He creates and drives the myEmerg strategy and his energy is seamlessly growing the wings of every team member. When he is not thinking about myEmerg, you will find him exploring, reading, or enjoying new adventures.
Follow Gundars Rezevskis:
About myEmerg: myEmerg provides simple access to instant personalized primary care.
Leith Jaber
Co-Founder & COO of MunchQuick
Follow Leith Jaber:
About MunchQuick: At MunchQuick we are fighting food insecurity in America by creating a sustainable business around delivering delicious food quickly.
Davide Vigano
Co-Founder & CEO of Sensoria
Davide Vigano’ is cofounder and CEO of Sensoria Inc. Sensoria design, develop and produce bio-sensing wearable devices that improve people’s lives. Davide is a former Microsoft Executive with over 25 years of sales, marketing and extensive product management experience. Joined the Mac Works, Mac Office teams in 1987 and more recently served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line. He acted as Vice President of the Worldwide SMSP Medium Business division which he grew 18% YOY to over $14B. Davide brought the Italian Microsoft Business and Enterprise operations to number one in the world for contribution margin, $1B in revenues, 6th largest subsidiary overall.
Follow Davide Vigano:
About Sensoria, Sensoria Health: Sensoria designs, develops, and produces body-sensing wearable devices.
Ross Baird
Co-Founder of VilCap Investments
Ross developed the Village Capital concept in 2009, and has led the development of programs worldwide. Before launching Village Capital, he worked with First Light Ventures, a seed fund focused on impact investments. Prior to First Light, Ross worked on the development of four education-related start-up ventures: the Indian School Finance Company in Hyderabad, India, the National College Advising Corps in Chapel Hill, North Carolina, and two ventures using technology to promote civic participation. He has a MPhil from the University of Oxford, where he was a Marshall Scholar, and a BA from the University of Virginia, where he was a Truman Scholar and a Jefferson Scholar. Contact: ross@vilcap.com
Follow Ross Baird:
About VilCap Investments, Village Capital: VilCap Investments deploys critical risk capital to early-stage companies peer-selected from Village Capital accelerator programs.
Dan Stachelski
Founder & CEO of ICAN Autism
Dan is a Washington native. He grew up in the city of Marysville. He attended Western Washington University, earning his Bachelor of Science in Communication Sciences and Disorders. He then attended Southern Illinois University (SIU), earning his Master of Science in Communication Disorders and Sciences. Dan has been studying and working in the field of Speech and Language Pathology since 2000. During his time at Southern Illinois, he helped create a rural outreach program for children with autism in collaboration with the Behavior Analysis and Treatment program. This program provided treatment, education and parent support. After graduating SIU he returned to Washington and worked in a variety of settings always maintaining a caseload of children with autism. Dan then began his own private practice, providing intervention in the home environment. During this time he was able to learn a significant amount about the needs of the children, and utilizing the experiences he had from his past, he had a vision to create a comprehensive facility that supported the needs of children with autism all in one place. By integrating providers, allowing them to team around treatment he felt that this would create the best outcomes and future for the children. Since opening Lakeside Center for Autism in 2009, the facility has grown to include 7 different disciplines, 22 treatment providers and 12 plus programs. Dan and his wife Amy have four daughters, Bailey, Peyton, Madden and Britton. He loves spending time with his family, traveling and being out on the water wakeboarding.
Follow Dan Stachelski:
About ICAN Autism: ICAN is an organization with a vast number of employees meeting the needs of individuals with communication disorders in the community.
Amy Stachelski
Founder & Vice President of Marketing of ICAN Autism
Colleges: Western Washington University Degrees: BA in Communications Amy has worked in the Marketing & Sales field for the last 7 years and is now so excited to be a part of LCA. Working with the LCA families has been amazing & very inspiring. She enjoys event planning, being a part of the community & meeting new people. She is very passionate about helping families & supporting the Autism community. In her spare time, Amy loves spending time with her husband and 3 little girls, being outdoors, boating & traveling.
Follow Amy Stachelski:
About ICAN Autism: ICAN is an organization with a vast number of employees meeting the needs of individuals with communication disorders in the community.
Michael Sandoval
Founder , CEO & Chairman of Atigeo
Follow Michael Sandoval:
About AI Research, Atigeo: Compassionate technology for a wiser planet. xPatterns big data analytics platform – illuminating analysis & rapid application deployment.
Dale Dell’Ario
Founder and CTO of Ario
Dale is the Founder and CTO of Ario, a company he started as a result of his interest and work in lighting, and the realization that the environment created by built spaces can and should be as dynamic as nature. Prior to Ario he was a mechanical engineering consultant developing products for commercial and medical companies. Before that his design career included nearly 20 years with medical companies, Olympic Medical, and SpaceLabs medical, building photo therapy and monitoring products in the roles of mechanical engineer, project manager, program manager, and engineering manager. He contributed to the development of commercial and computing products in similar roles for Hinds-Bock Co,, Ridge Computers, and Hewlett-Packard. His technical expertise lies in Product and Industrial design, and includes design management, engineering analysis, and regulatory compliance. Personal interests include lighting as functional art sculpture, home building, small land owner forestry, and yoga.
Follow Dale Dell’Ario:
About Ario: Ario creates circadian lighting solution that makes it easy for people to lead healthier lives.
Bing Chen
Co-Founder and Product Lead of Ario
Bing Chen is the founder of Ario.
Follow Bing Chen:
About Ario: Ario creates circadian lighting solution that makes it easy for people to lead healthier lives.
Avi Hoffer
Founder & CEO of Experchat, Inc
Follow Avi Hoffer:
About Experchat, Inc: Digital Marketplace for Top Beauty & Fashion Experts
Sasanka Yellamanchali
Chief Executive Officer & Co-Founder of WhiteSpace Health
Sasanka (SY) Yellamanchali has a passion and long track record for using data to transform operations and financials. The healthcare ecosystem is experiencing a significant transition and is being incentivized to efficiently deliver high-quality services at lower costs. WhiteSpace Health was founded to fulfill increased need to identify efficiencies, improve patient experience and determine the optimum resource utilization and productivity for the services. Before WSH, he was Sr. VP of worldwide Operations for MModal Inc. and prior to that, led services and solution management for Microsoft. WhiteSpace Health has a team of passionate technologists, data scientists, and experienced consultants.
Follow Sasanka Yellamanchali:
About DeliverHealth, WhiteSpace Health: WhiteSpace Health is a provider of data analytics and cloud healthcare intelligence.
Timothy Sidie
Founder, Lead Developer of Hipmed
Tim Sidie is a solutions engineer at Rigado.
Follow Timothy Sidie:
About BTCS, Hipmed, Rigado: Field-deployable smartphone-based medical technology to bring modern healthcare to disadvantaged regions
John Hoekman
Co-Founder, Chief Scientific Officer, Chief Technology, and Development Officer of Impel NeuroPharma
John Hoekman has focused on nasal drug delivery with an emphasis on delivery targeting the central nervous system using innovative device design and drug delivery systems. His research experience includes working with Dr. William Frey, one of the pioneers of nose-to-brain drug delivery, and Dr. Rodney Ho at the University of Washington. His unique background in both Physics and Pharmaceutics led to the development of Impel NeuroPharma’s core nasal delivery technology, the Pressurized Olfactory Delivery (POD) devices, of which he is co-inventor.
Follow John Hoekman:
About Impel NeuroPharma: Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.
Peter Thompson
Co-Founder, Chairman, CEO of Silverback Therapeutics
Thompson is currently a Venture Partner with OrbiMed who brings over 20 years of industry experience. He co-founded and was CEO of Trubion Pharmaceuticals and co-founded Cleave BioSciences. In addition to Principia Biopharma, Dr. Thompson serves on the Boards of Cleave BioSciences, Anthera, Methylgene and Response Biomedical. He was an executive of Chiron Corporation and Becton Dickinson. Dr. Thompson is an Ernst & Young Entrepreneur of the Year awardee, an Affiliate Professor of Neurosurgery at the University of Washington, an inventor on numerous patents, and a board-certified internist and oncologist. He was on staff at the National Cancer Institute following his internal medicine training at Yale University. Dr. Thompson received ScB and MD degrees from Brown University.
Follow Peter Thompson:
About Cleave Therapeutics, OrbiMed, Silverback Therapeutics: Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
Robert Barry
Co-Founder and Chairman of STASYS
Bob brings over 25 years of multifaceted experience in the medical device industry, from founding and funding novel inventions to designing and manufacturing to supporting clinical trials to finally commercializing and driving product adoption. Prior to founding Uptake Medical, he co-founded CoAptus Medical and served as Director of Product Development for Spiration (acquired by Olympus in 2010). Prior to those engagements, Bob spent 15 years in product development and manufacturing capacities with various medical technology firms, including Boston Scientific, Pfizer, Universal Medical Instruments, and Bausch & Lomb. He is an inventor on over 25 issued patents in the fields of cardiology, radiology, pulmonology and thoracic surgery, and he holds a Bachelor’s degree in Engineering from Rochester Institute of Technology.
Follow Robert Barry:
About Bausch & Lomb, Morair Medtech, LLC, STASYS, WINGS: Stasys Medical is a developer of a patient-focused test method for analyzing blood clotting disorders and platelet dysfunction.
Nathan White
Co-Founder and Clinical Consultant of STASYS
Nathan is an Assistant Professor of Emergency Medicine and Adjunct Professor of Mechanical and Bioengineering at the University of Washington. Dr. White is a graduate of Wayne State University School of Medicine, and completed training in Emergency Medicine at the University of Cincinnati. He then completed post-doctoral research training in hemostasis and critical injury at the Virginia Commonwealth University Reanimation Engineering Shock Center. Dr. White is a practicing physician at the Harborview Medical Center Emergency Department, the region’s only major trauma center, and conducts an active research program focused on hemostasis during critical illness and injury.
Follow Nathan White:
About STASYS, University of Washington, University of Washington School of Medicine: Stasys Medical is a developer of a patient-focused test method for analyzing blood clotting disorders and platelet dysfunction.
Benjamin Fels
CEO and Founder of Macro-Eyes
Benjamin leads teams that innovate. He is the founder and CEO of macro-eyes: an AI company making the delivery of health care predictive, everywhere.
Follow Benjamin Fels:
About Macro-Eyes, The Draper Richards Kaplan Foundation, World Health Organization: Macro-Eyes is an AI company. Our technology makes crucial systems resilient.
John Magnani
Co-Founder, Vice President, CSO & SVP of Research of GlycoMimetics
John Magnani is an expert in glycobiology having identified and characterized many carbohydrate tumor antigens, such as CA19-9, and developed fundamental technology for the identification of functional carbohydrate epitopes. Dr. Magnani is the discoverer of Sialyl Lewisa and its functions. He was the first to identify the binding domain to the selectins common to both Sialyl Lewisa and Sialyl Lewisx and used this information to develop potent selectin antagonists. Prior to co-founding GlycoMimetics, Dr. Magnani founded and led GlycoTech Corporation as its President and CEO. Previously, he helped co-found the U.S. subsidiary of BioCarb and became its Vice President of Research. Dr. Magnani received his Ph.D. from Princeton University and then joined the Laboratory of Biological Pharmacology of the National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, (NIADDK) of the National Institutes of Health. He remained at the NIH for ten years, finally serving as a tenured Research Chemist.
Follow John Magnani:
About GlycoMimetics, GlycoTech Corporation: GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Karen D. Cuthrell
Founder & CEO of The Feeling Friends
Hi, my name is Karen Cuthrell and I am the founder of The Feelings Company, a cutting-edge educational company that creates tools for educators to teach children emotional intelligence at and early age. Our mission is to grow children emotionally stronger. I am an entrepreneur, educator, author, researcher and creator of The Feeling Friends Educational Kit, an engaging and all-inclusive educational kit that gives educators the tools to make sure that early learners have the foundation to become emotionally successful. I am the CEO (Chief Emotions Officer) and I am responsible for running the day-to-day operations of The Feelings Company. My passion is creating and teaching everyone that I meet that LOVE is the most important Feeling!
Follow Karen D. Cuthrell:
About The Feeling Friends: Feeling Friends is an aromatherapy sensory tool for kids and teens to help manage moods to promote an overall well-balanced child.
Sina Torabi
Co-Founder and COO of Medsien
Sina Torabi is the Co-Founder & COO at Medsien.
Follow Sina Torabi:
About Medsien: Chronic Care Management Simplified
Colette Courtion
CEO and Founder of Joylux
Colette Courtion is an award-winning consumer marketer and business leader who has founded and served as CEO to three medical aesthetic companies, including her most recent company, Joylux- a global femtech company creating innovative medical devices and products that solve pelvic floor issues, such as incontinence and vaginal dryness. Colette has been featured in numerous business publications, such as Forbes and Inc, and her products have received accolades from consumer magazines like Vogue, In Style and Tatler. Puget Sound Business Journal named her as one of the Top 15 Women of Influence and Top 40 Under 40 leaders in Seattle. Colette was previously a marketing executive at Starbucks, where she was responsible for building and running the Starbucks Card, a multi-billion-dollar program. She is the proud mother to a very active 3.5 boy.
Follow Colette Courtion:
About Joylux: Joylux is a health and wellness company that specializes in women’s health and wellness.
Hank Werronen
Co-Founder and Sr. Advisor of PHRQL
Hank Werronen is Co-Founder and Sr. Advisor at PHRQL.
Follow Hank Werronen:
About ExtinQual, PHRQL: PHQRL Provides e-wellness management systems that deliver medical nutrition therapy, diabetes management education, and wellness counseling.
Jordan Schindler
Founder & CEO of Nufabrx
I founded texdel (formerly Nufabrx) in 2011 after a trip to the dermatologist where I learned that pillowcases are one of the leading causes of acne/blemishes, and we are supposed to wash our pillowcases every 2 to 3 days. For teens and college students, this is not going to happen! So off I went to find a solution. After years of R&D, fine tuning and teaming up with a brilliant PhD formulation scientist from Minneapolis, we developed four patent-pending “platform” technologies that enable the secure and controlled delivery of “Active” ingredients via yarn to the skin over an extended period of time, and through hundreds of laundering cycles. Textile yarns can now be enhanced to provide the wearer performance improving, healing, and aesthetic capabilities. Textile-Based Delivery is proud to partner with one of the most innovative and proven yarn manufacturers in America. Together we have developed the processes to rapidly and reliably produce Active-enabled yarn for use by your preferred manufacturers.
Follow Jordan Schindler:
About EO Charlotte, Nufabrx, Textile-Based Delivery: Nufabrx manufactures pillowcases designed to actively fight blemishes while its users are asleep.
Swatee Surve
Founder & CEO of Litesprite
Swatee Surve, is Founder & CEO of Litesprite and is a leader who has developed and launched disruptive technology-based healthcare businesses for Microsoft, Nike, T-Mobile, Premera Blue Cross and Eastman Kodak. These commercialization projects led to several patents including Nike’s first wearable technology patents. Surve has an MBA from the University of Chicago, an MSME in Biomechanics from Pennsylvania State University, and a BS in Bioengineering from the University of Illinois at Chicago. She has been featured in international, national, and regional media outlets including Huffington Post, International Business Times, NPR’s KUOW’s Morning Edition, APM: Marketplace, VentureBeat, Kauffman Foundation, and iMedicalapps.
Follow Swatee Surve:
About Litesprite: Health Games for chronic conditions
Dr. Darren White
CEO / Co-Founder of ADURO
Follow Dr. Darren White:
About ADURO: Coaching, Biometrics and Engagement Health Tech Company
Ronald Erickson
Founder , Chairman of Know Labs
Ronald Erickson has been a director and officer of Visualant since April 24, 2003. He currently serves as the Company’s Chief Executive Officer and President. He was appointed to the positions of CEO and President on November 10, 2009. Earlier, he was appointed President and Chief Executive Officer of the Company on September 29, 2003, and resigned from this position on August 31, 2004 at which time he was appointed Chairman of the Board. A seasoned executive with more than 30 years of experience in the high technology, telecommunications, micro-computer, and digital media industries, Mr. Erickson was the founder of Visualant. In addition to his Visualant responsibilities he also serves as Chairman of Tristit Global,, Inc., a mobile application development and distribution company and eCharge Corporation an Internet based transaction processing company. He is formerly Chairman, CEO and Co-Founder of Blue Frog Media, a mobile media and entertainment company; Chairman, CEO and Co-founder of GlobalTel Resources, a provider of telecommunications services; Chairman, Interim President and CEO of Egghead Software, Inc. the large software reseller where he was an original investor; Chairman and CEO of NBI, Inc.; and Co-founder of MicroRim, Inc. the database software developer. Earlier, Mr. Erickson practiced law in Seattle and worked in public policy in Washington, DC and New York, NY. Additionally, Mr. Erickson has been an angel investor and board member of a number of public and private technology companies. In addition to his business activities Mr. Erickson serves on the Board of Trustees of Central Washington University where he received his BA degree. He also holds a MA from the University of Wyoming and a JD from the University of California, Davis. He is licensed to practice law in the State of Washington.
Follow Ronald Erickson:
About Know Labs: Know Labs’ revolutionary Bio-RFID platform is changing how we can analyze molecules non-invasively.
Daniela Luzi Tudor
Co-Founder and CEO of WEconnect Health Management
Daniela Luzi Tudor is the co-founder and CEO of Pala-linq, recently releasing their first product the WEconnect mobile app, an on-the-go custom support and connection system for those in recovery from drug and alcohol addiction; helping prevent relapse. The venture is guided by Daniela Luzi Tudor’s core mission: using the vast potential of technology to connect people and communities for physical, mental and spiritual health. Daniela Luzi Tudor’s career has had a dual focus on entrepreneurship and intrapreneurship. She has founded or been instrumental in three start-ups: Pala-linq, The Beats Running Events, and SoundStrokes. She has also built and managed consulting teams for large enterprise clients including: Union Bank, Microsoft and IT departments of major motion picture studios. The story behind Daniela Luzi Tudor’s inspiration for Pala-linq and work on the WEconnect mobile app has been featured in Forbes, TechCrunch and Geekwire and most recently winning TechCrunch Wildcard at Disrupt Battlefield 2016.
Follow Daniela Luzi Tudor:
About WEconnect Health Management: WEconnect Health Management provides a patient engagement solution for addiction rehabilitation providers or centers.
Michael Milken
Founder and Chairman of Milken Institute
Mike Milken’s career has mirrored his three main professional passions: medical research, education and finance. In each, he has been uniquely successful in creating value, whether measured in lives saved (Fortune magazine called him “The Man Who Changed Medicine”), students inspired or jobs created. Between 1969 and 1989, he financed more than 3,200 companies that collectively created millions of jobs. His philanthropy, which began in the 1970s and paralleled his business career, expanded in 1982 with the establishment of the Milken Family Foundation. He also heads the Prostate Cancer Foundation and FasterCures, a Washington-based think tank that removes barriers to progress against all life-threatening diseases. Mike joined leading physicians in launching the Melanoma Research Alliance to support work on fatal skin cancers. He is chairman of the widely respected and influential Milken Institute, an economic think tank whose annual Global Conference brings more than 3,000 leaders from 60 nations to Los Angeles each spring. Mike graduated from Berkeley with highest honors and earned his MBA at the Wharton School. He and his wife, Lori, have three children and four grandchildren and celebrated their 41st anniversary this year.
Follow Michael Milken:
About Milken Institute: Milken Institute is an independent economic think tank based in Santa Monica, California.
Harjinder Sandhu
Founder / CEO of Saykara
Harjinder is a serial entrepreneur in the healthcare technology space and has stood at the forefront of innovations in speech recognition and machine learning for more than 20 years. Earlier in his career, Harjinder co-founded MedRemote, a healthcare-focused speech recognition company acquired in 2007 by Nuance. He then served for five years as Vice President and Chief Technologist of Nuance’s Healthcare R&D division. He also co-founded the patient engagement company, Twistle, and remains on its Board of Directors. Harjinder holds a doctoral degree (Ph.D.) and master’s degree (M.Sc.) in Computer Science from the University of Toronto and a bachelor’s degree (B.Sc.) in Computer Science from The University of British Columbia. He is a former Assistant Professor of Computer Science at York University and Visiting Scientist at IBM.
Follow Harjinder Sandhu:
About Saykara: Saykara has developed the first voice-enabled mobile AI assistant to automate physician charting.
Frank R. Jones
Founder ,President, Chief Scientific Officer & CEO of Etubics
Dr. Jones is a seasoned bio-tech entrepreneur. As the founder of Etubics, Dr. Jones has served as the Company’s Chairman of the Board of Directors, Chief Executive Officer and Chief Scientific Officer since its inception. He is the Principle Investigator on many of the company’s National Institute of Health grants and contracts, which total over $10 million. He also designs and directs the clinical programs for the Company. From 1981 to 1996, Dr. Jones served as Founding Chairman and Chief Executive Officer of the publically traded medical device company IMRÉ CORPORATION (now Cypress Biosciences), which focused on immunoadsorption treatments for various human diseases. From 1996 to 1998, Dr. Jones was Chairman and Chief Executive Officer of Scius Corporation, a private company. From 1998 to 2003 he consulted to the biotechnology industry and was the Managing Partner of Haidas Ranches, LLC a family-owned land development company. From 1983 until 1986, Dr. Jones was Director of the Immune Response Program of the Pacific Northwest Research Foundation in Seattle. He was a Researcher in the Department of Complement and Effector Biology at Memorial Sloan Kettering Cancer Center (“MSKCC”) in New York City from 1980 to 1981 and was a Research Associate in the Laboratory of Veterinary Oncology at MSKCC from 1981 to 1983. Dr. Jones holds a PhD degree from the University of Washington in Biological Structure/Cellular Immunology. He has 10 patents to his name and has published over 45 peer reviewed scientific papers.
Follow Frank R. Jones:
About Etubics: Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.
Tom Clement
Co-Founder, President and CEO of Aqueduct Critical Care
Tom Clement is a seasoned medical device entrepreneur having brought multiple medical devices to the market over his 30+ year career. The products he has been responsible for bringing to market span Neurosurgery, Interventional Cardiology, Vascular Surgery, Endoscopy, and Radiology. These products include both PMA and 510(k) products. Tom Clement co-founded Pathway Medical Technologies, Inc. in 1998 and served as CEO until September 2008, as the company developed and brought to market its flagship product, the Jetstream System for treatment of peripheral arterial diseases. He previously was a founding employee and held senior management roles at Heart Technology which was headquartered in the Seattle area. When Boston Scientific acquired Heart Technology, Tom Clement took on responsibility for the emerging cardiovascular technologies group of the Scimed Division. Tom Clement is the immediate past Chairman of the Board of Directors for the Washington Biotechnology & Biomedical Association (WBBA) and serves on two private company boards, one public company board, and several not-for profit boards and Advisory Boards. He was one of the founders of the medtech angel group, WINGS, where he is an active member of the screening committee.
Follow Tom Clement:
About Aqueduct Critical Care: Aqueduct Critical Care addresses the critical care problem of managing inter-cranial pressure.
Samuel Browd
Co-Founder and Chief Medical Officer of Aqueduct Critical Care
Samuel Browd is an attending neurosurgeon at Seattle Children’s Hospital where he performs over 160 shunt procedures and over 300 procedures annually. As a surgeon performing a high volume of procedures every year, Samuel Browd is keenly aware of the problems with current technologies marketed for cerebral spinal fluid management. In fact, the inadequacy of existing technology was his motivation to invent improved technology and start Aqueduct. Inventing is not new to Samuel Browd; he has filed and received a patent in a completely different area, a vacuum fixation head bag to immobilize heads – a product that is now being evaluated for commercialization. Samuel Browd is the lead site investigator for the Hydrocephalus Clinical Research Network (HCRN) at the University of Washington (UW), which has been involved in protocol implementation and data gathering for improvement of hydrocephalus treatment strategies. Samuel Browd’s research efforts outside of the HCRN have focused on image guided neuro-navigation for optimal catheter positioning during shunt placement. He is the co-founder of another company to pursue that technology. Samuel Browd is currently collaborating on various basic science projects to determine the causes of hydrocephalus and shunt malfunction. Samuel Browd is a Professor of Neurological Surgery at the UW School of Medicine where he is the Director of the Hydrocephalus Program.
Follow Samuel Browd:
About Aqueduct Critical Care, Proprio Vision, University of Washington: Aqueduct Critical Care addresses the critical care problem of managing inter-cranial pressure.
Walter Smith
Co-Founder and CTO of CareZone
Follow Walter Smith:
About CareZone: CareZone makes it easy to manage multiple medications, organize health information, and access health services from your smartphone.
Tom Seery
Executive Chairman/ Founder of RealSelf
Experienced Chief Executive Officer with a demonstrated history of working in the medical aesthetics and internet industry. Strong business development professional skilled in Digital Strategy, Social Media, Leadership, Business Development, and Growth Marketing Strategy. Podcaster, speaker and educator in aesthetic consumer trends and attitudes, practice marketing, and entrepreneurship. Actively support non-profits and medical institutions that expand reconstructive surgical capacity in communities around the world.
Follow Tom Seery:
About RealSelf: RealSelf is an online community where people can ask questions, share experiences and connect with doctors providing cosmetic treatments.
Ramanan Laxminarayan
CEO, Founder & Chairman of HealthCubed
Ramanan is an international public health veteran and a leading global expert on the understanding of antibiotic resistance as a problem of managing a shared global resource. He realized an unmet need for a product that can address public health challenges of the world. The key characteristics of this product were that it had to be easy to use, quick and affordable. HealthCubed was born to address this need. Ramanan, is also an economist, engineer and epidemiologist by training and is the director and Senior Fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP) in Washington, D.C., and the Senior Research Scholar and Lecturer at Princeton University. He has served on the U.S. President’s Council of Advisors on Science and Technology’s antimicrobial resistance working group and is a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance. He is a series editor of the Disease Control Priorities for Developing Countries, 3rd edition. In 2012, Ramanan created the Immunization Technical Support Unit that supports the immunization program of the Ministry of Health and Family Welfare of the Government of India and which is credited with helping rapidly improve vaccination coverage and the introduction of new vaccines. As Vice President, Research and Policy at the Public Health Foundation of India between 2011 and 2015, he led the growth of a research division from 80 to over 700 technical and research staff. Whenever he has some time he would be either working on his new book or spending time with his family.
Follow Ramanan Laxminarayan:
About HealthCubed, Princeton University: HealthCubed is a portable diagnosis system that can be used easily anywhere by anyone.
Grace Gee
Co-Founder & CEO of HoneyInsured
Founder at HoneyInsured.
Follow Grace Gee:
About HoneyInsured: Health Insurance Recommendation Engine
Eugene Wang
Co-Founder & CTO of HoneyInsured
Founder at HoneyInsured.
Follow Eugene Wang:
About HoneyInsured: Health Insurance Recommendation Engine
Dr. Melissa Hunfalvay
Co-Founder & Chief Science Officer of RightEye
Dr. Melissa Hunfalvay is a former professional tennis athlete, coach and scientist. Originally from Australia, Melissa played on the professional tennis circuit. She was the youngest female coach in NCAA1 history and was part of a team ranked number one in the world for coaching staff. Dr. Hunfalvay completed her Doctorate in Kinesiology (Sport Science and Psychology) from the University of Virginia and Masters in Clinical Psychology from Campbell University. She began her scientific career, 20 years ago, by examining human performance with the goal of understanding where professional versus amateur athlete’s look. She found that performance could be improved based on where a person looked at critical moments in time. Using the same technology and scientific methodology she has created dozens of products used to examine athletic performance, autism spectrum disorder, ADHD, vision disorders, neurological disorders and reading disorders. She has also developed therapies and training programs based on eye-tracking assessments. Dr. Hunfalvay is unique in that her background enables her to build products based on scientific rigor that are practical and easy to understand by the end user. Her expertise solves scientific questions using technology to better understand human behavior. She has published many works from peer reviewed science to practical applications to technology articles and book chapters. She has presented at over 50 conferences. As RightEye’s Chief Science Officer, Melissa is responsible for all new and existing product development efforts and she also leads RightEye’s research branch. She is driven by her passion to build eye-tracking solutions to positively impact everyday lives.
Follow Dr. Melissa Hunfalvay:
About RightEye: RightEye leverages proven scientific research and a patented cloud-based software platform to deliver any eye movement test or therapy.
Adam Gross
Co-Founder & CEO of RightEye
Adam Gross is a Co-Founder & CEO at RightEye.
Follow Adam Gross:
About RightEye: RightEye leverages proven scientific research and a patented cloud-based software platform to deliver any eye movement test or therapy.
David Granville
Co-Founder & CSO of viDA Therapeutics
David Granville, Ph.D. Co-founder and Scientific Founder of the Company in 2008, David Granville serves as the Company’s Chief Scientific Officer (CSO) and is a Full Professor and Director of the GEM Facility at the Providence Heart + Lung Institute at St. Paul’s Hospital, University of British Columbia (UBC). David Granville completed his Ph.D. at UBC and post-doctoral training at the Scripps Research Institute (La Jolla, CA). He worked in preclinical pharmacology at QLT Inc. from 1994-2000. David Granville was recruited to UBC in 2003 as a Tier II Canada Research Chair and Michael Smith Foundation for Health Research Scholar. Since then, David Granville has received numerous awards for his scholarly and research achievements including a Canada Top 40 Under 40™ award, 2010 Business in Vancouver Forty Under 40 award, 2006 UBC Outstanding Young Alumnus Award, 2007 Simon Fraser University Academic Alumnus Award, 2008 Canadian Academy of Pathology Scientist award and was a finalist for the prestigious 2007 Louis and Arnold Katz Basic Science Prize at the American Heart Association Scientific Sessions.
Follow David Granville:
About Creative Destruction Lab (CDL), St. Paul’s Hospital, viDA Therapeutics: viDA Therapeutics is a Canada-based biotech company that develops treatments for chronic inflammatory and age-related diseases.
Pradeep Sundar
Founder of Doximple
Founder at Doximple
Follow Pradeep Sundar:
About Doximple: Doximple provides healthcare services.
Matthew Reyes
Founder of Doximple
Follow Matthew Reyes:
About Doximple: Doximple provides healthcare services.
Francisco Leon
Co-Founder and Chief Scientific Officer of Provention Bio
Francisco Leon, MD, Ph.D. is the scientific co-founder of Provention Bio, Inc. An immunologist by training, Francisco Leon has more than two decades of academic research and biopharma industry experience, with an expertise in immune tolerance. Previously, Francisco Leon was the Chief Executive Officer and Chief Medical Officer of Celimmune, LLC, a clinical stage immunotherapy company dedicated to developing transformational therapies for celiac disease and other serious immune-mediated diseases. Prior to Celimmune, Francisco Leon served as Vice President and Head of Translational Medicine/Immunology at Johnson & Johnson’s Janssen Pharmaceuticals, where he led early-stage clinical development in immunology. Francisco Leon’s professional experience is also highlighted by positions of increasing responsibility at several life sciences companies, including Chief Medical Officer of Alba Therapeutics, Director of Clinical Development, Inflammation & Respiratory at Medimmune and Director of Clinical Discovery, Immunology & Oncology at Bristol-Myers Squibb. Prior to entering the biopharma industry, Francisco Leon served as a Postdoctoral Fellow at the National Institutes for Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). In 2011, he became an Associate Professor of Medicine at Jefferson Medical College in Philadelphia, where he continues to contribute to the clinical research efforts of the Department of Gastroenterology. Francisco Leon earned his MD and Ph.D. from Autónoma University in Madrid Spain and has authored or co-authored more than 80 peer-reviewed articles, book chapters and patents.
Follow Francisco Leon:
About Provention Bio: Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics.
Richard Howe
Founder and CEO of AXIOM Systems
As founder and CEO of AXIOM Systems, Rich has been responsible for establishing and building AXIOM. With over 30 years of business experience within both information technology and healthcare, Rich insures that AXIOM consistently exceeds our clients’ expectations while maintaining the type of growth necessary to be recognized as the industries healthcare IT experts. Prior to founding AXIOM, Rich held the position of Vice President of Health Care Systems for a national consulting company. Previously, Rich played a strategic management role for AMISYS (now part of DST Health Solutions), a leading managed care software vendor.Rich has also been instrumental in the design and development of AXIOM’s products which meet the diverse needs of payers and providers in the management of healthcare transactions.
Follow Richard Howe:
About AXIOM Systems: AXIOM Systems provides healthcare IT products and solutions.
Jesse Salk
Co-Founder & Chief Scientific Officer of TwinStrand Biosciences
Jesse Salk currently works as the CEO and co-founder of TwinStrand Biosciences. He previously worked at the University of Washington as a senior fellow in the division of oncology.
Follow Jesse Salk:
About TwinStrand Biosciences, TwinStrand Biosciences: TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
Kevin MacDonald
Co-Founder & CEO of Kit Check
Follow Kevin MacDonald:
About Kit Check: KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking.
Seulki Lee
Founder and CEO of Neuraly
Seulki Lee is the Founder and CEO at D&D Pharmatech.
Follow Seulki Lee:
About D&D Pharmatech, Neuraly, Precision Molecular, Theraly Pharmaceuticals, Valted Seq: Neuraly is a startup biotech company.
Trevor Watkins
Co-Founder & COO of Volt Athletics
Trevor manages the operations of Volt Athletics, including overseeing lead generation, product development, and financials. He previously served as Volt’s CTO until the addition of Brian McNaboe in August 2014. Trevor has been in the IT field for over 8 years, including 5 years at Accenture where he worked at notable clients such as T-Mobile, AT&T and The Bill & Melinda Gates Foundation. Trevor has a BS in Computer Science and Business from Pepperdine University, where he played midfield and was the President and Captain of the Pepperdine Men’s Lacrosse Team.
Follow Trevor Watkins:
About Volt Athletics: Volt Athletics provides an AI-powered training system that delivers personalized sport-specific workouts.
Dan Giuliani
Co-Founder & CEO of Volt Athletics
Dan co-founded Volt Athletics in 2011 and directs the strategic vision of the company. He was an Adjunct Professor of Sport Performance at the University of Washington from 2014-2018 and has been a CSCS-certified strength coach by the NSCA since 2009. Dan has a Masters in Sport Administration and Leadership from Seattle University and a BA in Government from Colby College where he played football for the Mules.
Follow Dan Giuliani:
About Volt Athletics: Volt Athletics provides an AI-powered training system that delivers personalized sport-specific workouts.
Gary Frank
Co-Founder of Prevencio
Over the past 25 years, Gary Frank, as Principal of Global Ventures, LLC, has been directly involved with medical and other companies to optimize their business strategies by raising early stage capital, mezzanine and second round financing, and by providing liquidity events through M&A and public offerings. Mr. Frank served as board member and sales and marketing consultant for Woman’s Wellbeing, Inc., where he helped facilitate the sale of the company to Medifast, Inc. (NYSE: AMX). Previously, Frank was President of Performance USA, Inc., a division of Sunrise Medical Company, where he was responsible for operations. His previous Company, Monarch America, Inc., was sold to Sunrise Medical. Mr. Frank has experience and expertise in cardiology sales and served as Vice President of Sales and Marketing for Quinton Instrument Company (now Cardiac Science), where he was responsible for worldwide sales and marketing. In addition he has extensive experience in medical sales of cardiovascular and orthopedic surgical products for Johnson and Johnson (NYSE: JNJ), where he was the Divisional Sales Manager and received numerous, national sales awards. Mr. Frank has a B.A. from Marquette University.
Follow Gary Frank:
About : Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease.
Björn Woltermann
Founder & CEO of Katalyst
Follow Björn Woltermann:
About Katalyst: Katalyst is making the world’s most efficient workout, Electro Muscle Stimulation (EMS) training, available to every body.
